Angiology: Open Access
Open Access

Recent Advances in the Treatment of Venous Stasis Ulcers Exploring Surgical and Non-Surgical Approaches

Laura Mitchell^{* *}Correspondence: Laura Mitchell, Center for Medical Electronics, University of Barcelona, Barcelona, Spain, Email:

Author info »

Description

The formation of venous stasis ulcers is largely a consequence of chronic venous insufficiency. When the venous valves in the legs become weakened or damaged, blood cannot flow properly back to the heart and begins to pool in the veins. This causes increased pressure within the veins (venous hypertension), which leads to the leakage of fluid and proteins into the surrounding tissues. The resulting edema and poor oxygenation of the tissue create an environment conducive to ulceration, as the skin and underlying tissues become more vulnerable to injury and infection.

In addition to venous hypertension, inflammation plays a major role in the development. The stagnation of blood in the veins leads to the accumulation of inflammatory cells and mediators in the affected area. These inflammatory responses can further disrupt tissue healing and contribute to the chronicity of the wound. Over time, the lack of adequate venous return, coupled with insufficient oxygen and nutrients, makes it challenging for the body to heal the ulcer, resulting in a persistent wound.The management of venous stasis ulcers typically involves a combination of conservative measures, such as compression therapy and advanced wound care techniques. Over the years, new treatment modalities have emerged to address the underlying venous insufficiency and enhance the wound healing process.

Compression therapy remains the cornerstone of venous stasis ulcer treatment. By applying controlled pressure to the affected area, compression stockings or bandages help to reduce venous hypertension, improve venous return and reduce swelling. This, in turn, creates a more favorable environment for healing. Compression works by improving blood flow in the veins, thus reducing the risk of further fluid leakage into the tissues. In many cases, compression therapy alone is sufficient to facilitate ulcer healing, particularly in the early stages of venous stasis ulcer development.Recent innovations in compression therapy have led to the development of more comfortable and effective devices. New materials and technologies allow for better uniformity of compression and greater patient compliance. There are also custom-designed compression garments that are modified to the specific anatomy of the patient, offering more targeted pressure distribution.

Endovenous treatments, such as Endovenous Laser Therapy (EVLT) and Radiofrequency Ablation (RFA), are gaining prominence as effective therapies for the underlying venous insufficiency in patients with venous stasis ulcers. These minimally invasive procedures use heat to close the affected veins, thereby improving blood flow and reducing venous hypertension. EVLT and RFA have demonstrated significant efficacy in promoting the healing of venous stasis ulcers by addressing the root cause of venous reflux and reducing the risk of ulcer recurrence.These techniques work by using energy to collapse the incompetent veins, redirecting blood flow through healthier veins. Both methods are performed on an outpatient basis with minimal downtime, offering a quicker recovery compared to traditional surgical interventions. In a growing body of clinical studies, these endovenous treatments have been associated with improved ulcer healing times and reduced ulcer recurrence rates.

Topical treatments are essential for the management of venous stasis ulcers, helping to promote healing and prevent infection. Recent advances in wound care have introduced specialized dressings that create an optimal healing environment, facilitate moisture balance and provide protection against external contaminants. Dressings that contain silver, honey, or alginate have been shown to have antimicrobial and anti-inflammatory properties, helping to control infection and reduce the inflammatory response in the wound.In addition, bioengineered skin substitutes are becoming increasingly popular in the treatment of chronic wounds, including venous stasis ulcers. These products, which include living skin grafts or synthetic matrices, provide scaffolding for new tissue growth and enhance the body’s ability to heal the ulcer. These advanced wound care products have shown promise in accelerating the healing process and reducing the need for surgical intervention in patients with chronic, non-healing ulcers.

In addition to mechanical and surgical treatments, pharmacological interventions have been increasingly explored for their role in improving venous stasis ulcer healing. One class of medications that has gained attention is pentoxifylline, which improves blood flow by reducing blood viscosity and enhancing red blood cell flexibility. By improving microcirculatory function, pentoxifylline may aid in ulcer healing, particularly in patients with poor circulation.Another promising therapeutic class includes drugs that target the inflammatory response in venous ulcers. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) and corticosteroids, though used cautiously due to their potential to impair wound healing, may be beneficial in controlling excessive inflammation. Additionally, growth factors such as Platelet-Derived Growth Factor (PDGF) are being tested for their ability to stimulate tissue repair and collagen formation in chronic wounds, providing a potential adjunct to other wound care methods.

Conclusion

The treatment of venous stasis ulcers has advanced significantly in recent years, with both surgical and non-surgical options offering promising results. Compression therapy remains foundational in the treatment of these ulcers, while minimally invasive procedures like EVLT and RFA are showing considerable efficacy in addressing the underlying venous insufficiency. Topical wound care, including advanced dressings and bioengineered skin substitutes, plays a critical role in promoting healing, while pharmacological therapies are being explored for their ability to enhance blood flow and reduce inflammation. With continued advancements in treatment strategies and a deeper understanding of the healing mechanisms at play, patients with venous stasis ulcers are experiencing better outcomes and a greater quality of life.